Competition & Peer Data API & CSV Delivery

Weed Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Weed Inc (BUDZ) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2026
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/BUDZ/competitors
https://api.csimarket.com/api/v1/companies/BUDZ/relationships
https://api.csimarket.com/api/v1/companies/BUDZ/similar
Programmatic access for models, analytics, and integration workflows.

Weed Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
WEED, INC. - - - -
High-Confidence Competitors (3) 50% 100% 50% 50%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

BUDZ Stock Performance relative to its Competitors

BUDZ Competitors (weighted) Percent change over the selected range

Weed Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
66.7%beat U.S.A. 500
High-Confidence
(2 of 3)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
WEED, INC. - -
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (3) 40.4% 63.2%
Similar-Size Competitors (0) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Weed Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

BUDZ Stock Performance relative to High-Confidence Competitors

BUDZ High-Confidence Competitors (equal-weighted, 4) Percent change over the selected range

Weed Inc's Comment on Competition and Industry Peers

The company identifies its competitors as entities engaged in studying and sequencing cannabis DNA to develop medicines, rather than those involved in cultivating or selling cannabis for medicinal or recreational purposes. Named competitors include TRUL, TerrAscend Corporation (OTCQX: TCNNF), and Tilray Brands, Inc. (OTCQX). The company highlights its research team with decades of experience, over 14,000 square feet of dedicated research space, advanced DNA sequencing instruments capable of sequencing large DNA fragments, and proprietary bioinformatics software. The competitive landscape also encompasses suppliers of synthetic cannabinoids and cannabis extracts for research, as well as companies cultivating cannabis for herbal or non-pharmaceutical uses. Other organizations and universities working on cannabis genomics may compete for research funding but are not considered direct competitors. Next-generation sequencing technologies referenced include Illumina (Solexa), Roche 454, Ion Torrent (Proton/PGM), and SOLiD sequencing.
Competitor data is not yet available for Weed Inc.

Weed Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
OTCQX: TCNNF TerrAscend Corporation Named by the company 85% 2022 to 2026 3
TRUL Named by the company 85% 2022 to 2026 3
Ion torrent: Proton / PGM Named by the company 85% 2022 to 2026 3
TerrAscend Corporation Named by the company 85% 2022 to 2026 3
Roche 454 Named by the company 85% 2022 to 2026 3
OTCQX Tilray Brands, Inc. Named by the company 85% 2022 to 2026 3
Tilray Brands, Inc. Named by the company 85% 2022 to 2026 3
Illumina (Solexa) Named by the company 85% 2022 to 2026 3
SOLiD Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Weed Inc's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.